Hosted on MSN
BioLife Solutions raises 2025 revenue guidance to $100M–$103M as cell processing momentum accelerates
CEO Roderick de Greef reported, "We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters." Cell processing revenue ...
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related ...
Hosted on MSN
BioLife Solutions raises 2025 revenue guidance to $96M as cell processing momentum accelerates
CEO Roderick de Greef highlighted strong quarterly performance, stating that "cell processing revenue increased 33% year-over-year, driving a 31% increase in total revenue for the quarter." He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results